Cizzle Biotechnology (LON:CIZ) Shares Down 3.4% – Time to Sell?

Cizzle Biotechnology Holdings Plc (LON:CIZ)’s stock price was down 3.4% during trading on Monday . The company traded as low as GBX 1.80 and last traded at GBX 1.83. 6,536,470 shares changed hands during mid-day trading, an increase of 311% from the average session volume of 1,591,377 shares. The stock had previously closed at GBX 1.90.

Cizzle Biotechnology Price Performance

The stock’s 50 day moving average is GBX 2.53 and its two-hundred day moving average is GBX 2.20. The firm has a market capitalization of £7.80 million, a P/E ratio of -10.79 and a beta of 0.02.

Cizzle Biotechnology (LON:CIZ) last announced its quarterly earnings data on Tuesday, May 5th. The company reported GBX (0.17) earnings per share (EPS) for the quarter.

Cizzle Biotechnology Company Profile

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.